Dr. M. R. Vishwateja

Dr. M. R. Vishwateja is a Consultant Radiation Oncologist with over 7 years of clinical experience in advanced cancer care. He holds an MBBS from Osmania Medical College (2007) and a DNB in Radiation Oncology from Yashoda Cancer Institute, complemented by certification from the Indian College of Radiation Oncology (ICRO) in 2018. His foundation in comprehensive cancer management is further strengthened by formal training in palliative care, reflecting a patient-centred philosophy that extends beyond curative intent.

Dr. Vishwateja specializes in precision radiation therapy techniques including Image-Guided Radiation Therapy (IMRT), Volumetric Modulated Arc Therapy (VMAT), Stereotactic Body Radiation Therapy (SBRT), and Stereotactic Radiosurgery (SRS). He is proficient in MRI-guided radiotherapy and brachytherapy procedures, and brings expertise in total body irradiation (TBI) for complex hematologic malignancies. His clinical scope encompasses head and neck cancers, gastrointestinal, genitourinary, gynecological, and thoracic malignancies, treating a diverse patient population with individualized treatment protocols.

He regularly welcomes international patients from the Gulf region, Africa, and South Asia, offering consultations in English, Hindi, and Telugu. His approach combines cutting-edge technology with compassionate care, ensuring patients from abroad receive seamless coordination from initial assessment through follow-up. Dr. Vishwateja has worked across leading cancer institutions including MNJ Cancer Institute, St. Ann's Cancer Hospital in Warangal, and MGM Government Hospital, building extensive experience in multi-disciplinary oncology teams.

At Yashoda Hospitals, Somajiguda in Hyderabad, Dr. Vishwateja practices in a facility known for its modern radiotherapy infrastructure, experienced oncology nursing, and structured follow-up protocols. The hospital's location in Hyderabad—a major medical hub with excellent transport links—makes it accessible for international patients. His track record of managing over 150 satisfied patients (4.8-star rating) reflects consistent clinical outcomes and patient trust. International patients value his clarity in explaining complex treatment plans and his proactive management of side effects through integrated palliative support.